Bio-Rad Laboratories up 12.7% After Announcing Agreement with Luminex

Bio-Rad Laboratories BIO is trading higher on the session after the company announced Luminex LMNX and Bio-Rad are extending the global sales and distribution agreement until 2023. According to the company's news release, Bio-Rad will now offer the full range of Luminex's xMAP® systems including the MAGPIX system. Michael F. Pintek, senior vice president of operations at Luminex. ""We are very pleased to extend our sales and distribution agreement and to have Bio-Rad as a global distribution partner for MAGPIX. As a leader in the life science research market, Bio-Rad can provide researchers additional access for this highly innovative instrument that offers a broad range of applications. Together we can accelerate the pace of research and advance healthcare for people around the world." Bio-Rad Laboratories is currently trading at $115.97, a gain of $13.05 or 12.68%.